Back to search
FDAFDA · Food and drugs·Recall number D-1672-2012

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24

Published September 5, 2012 · Recall initiated: August 3, 2012

Summary

FDA records drug Class II recall D-1672-2012, published September 5, 2012 and initiated August 3, 2012. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 56,420 vials; Lot: 07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

What to do

Voluntary: Firm initiated · Letter

Get an email if PROPOFOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROPOFOL
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24 recalled?

Yes. FDA published recall D-1672-2012 on September 5, 2012. Reported hazard: Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROPOFOL.